trending Market Intelligence /marketintelligence/en/news-insights/trending/vkkeyicdeys8dn__hzyuyw2 content esgSubNav
In This List

Probi names interim CEO

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Probi names interim CEO

Probi AB (publ) appointed Ole Søgaard Andersen as interim CEO to replace Peter Nählstedt, effective March 14.

Andersen previously served as president of systems division and global vice president sales of marketing and application for Nutrition and Health at DuPont.

Probi plans to retain an executive search firm to recruit a new CEO.

Sweden-based Probi engages in the research, development, marketing and sale of probiotics for food, health and pharmaceutical companies.